Roche Receives FDA Clearance for cobas eplex Respiratory Panel 3
The FDA cleared Roche’s respiratory pathogen panel 3, designed for its automated cobas eplex system and customizable for local patient testing needs.
Story updates
02:30:59 PM UTC
SquawkNews
Roche received FDA 510(k) clearance for its cobas eplex respiratory pathogen panel 3, which detects up to 19 viral and bacterial targets and offers up to five customizable configurations.Material DetailsContext by AI AnalystThis is a portfolio expansion in Roche's established respiratory diagnostic…